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Abstract 
For this study, 56 lactating Holstein cows (143 ± 72 days in milk) were used in a randomized complete 
block design to evaluate 2 rumen-protected products compared to crystalline carnitine. Treatments were 
a) control, b) 3 grams/day crystalline L-carnitine (raw), c) 6 grams/day raw, d) 5 grams/day 40COAT (40% 
coating, 60% L-carnitine), e) 10 grams/day 40COAT, f) 7.5 grams/day 60COAT (60% coating, 40% L-
carnitine), and g) 15 grams/day 60COAT. Treatments were top-dressed to diets twice daily. The 14-day 
experiment included a 6-day baseline-measurement period with the final 2 days used for data and sample 
collection and an 8-day treatment period with the final 2 days used for data and sample collection. 
Plasma, urine, and milk samples were analyzed for L-carnitine. Crystalline (P < 0.001) and 40COAT (P = 
0.01) linearly increased plasma L-carnitine, and 60COAT tended to linearly increase plasma L-carnitine (P 
= 0.08). Total daily excretion (milk + urine) of L-carnitine averaged 1.52 ± 0.04 grams in controls, 
increased linearly with crystalline and 40COAT, and increased quadratically with 60COAT (all P < 0.05). 
Crystalline increased plasma L-carnitine and milk + urine L-carnitine more than 40COAT and 60COAT (all 
P < 0.05). Carnitine supplementation increased carnitine concentrations in plasma, milk, and urine; 
however, the rumen protection did not provide additional increases in concentration. 
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E. Titgemeyer, and B.J. Bradford
Summary
For this study, 56 lactating Holstein cows (143 ± 72 days in milk) were used in a ran-
domized complete block design to evaluate 2 rumen-protected products compared to 
crystalline carnitine. Treatments were a) control, b) 3 grams/day crystalline L-carnitine 
(raw), c) 6 grams/day raw, d) 5 grams/day 40COAT (40% coating, 60% L-carnitine), 
e) 10 grams/day 40COAT, f) 7.5 grams/day 60COAT (60% coating, 40% L-carnitine), 
and g) 15 grams/day 60COAT. Treatments were top-dressed to diets twice daily. The 
14-day experiment included a 6-day baseline-measurement period with the final 2 days 
used for data and sample collection and an 8-day treatment period with the final 2 days 
used for data and sample collection. Plasma, urine, and milk samples were analyzed for 
L-carnitine. Crystalline (P < 0.001) and 40COAT (P = 0.01) linearly increased plasma 
L-carnitine, and 60COAT tended to linearly increase plasma L-carnitine (P = 0.08). 
Total daily excretion (milk + urine) of L-carnitine averaged 1.52 ± 0.04 grams in con-
trols, increased linearly with crystalline and 40COAT, and increased quadratically with 
60COAT (all P < 0.05). Crystalline increased plasma L-carnitine and milk + urine 
L-carnitine more than 40COAT and 60COAT (all P < 0.05). Carnitine supplementa-
tion increased carnitine concentrations in plasma, milk, and urine; however, the rumen 
protection did not provide additional increases in concentration.
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Introduction 
Fatty liver is a common metabolic disease that affects postpartum dairy cows. Depressed 
feed intake and increased energy demands of lactation lead to negative energy balance 
that stimulates fat mobilization, often in excess of the liver’s oxidation capacity, causing 
liver lipid accumulation. L-carnitine stimulates hepatic fatty acid oxidation through 
increased transport of long chain fatty acids from the cytosol to mitochondria, and has 
been observed to decrease liver triglyceride accumulation during the transition period. 
L-carnitine is commonly degraded in the rumen, thus affecting its intestinal availability. 
An in vitro study estimated that 80% of dietary carnitine was degraded in rumen fluid 
after microbial adaptation. Studies implementing abomasal infusions have observed 
linear increases in urine, milk, plasma, and liver concentrations in response to infusions 
up to 6 grams/day. Rumen-protected products are intended to prevent degradation in 
1 Lonza, Inc., Allendale, NJ.
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the rumen and increase the amount reaching the small intestine for absorption. In this 
experiment, two rumen-protected carnitine products were supplemented in the diets 
of mid-lactation Holstein cows and the L-carnitine concentrations in milk, urine, and 
plasma were determined to assess their relative bioavailability. Production responses 
including milk yield, milk components, and feed intake were also determined. 
Experimental Procedures
For this study, 56 mid-lactation Holstein cows (143 ± 72 days in milk) from the Kansas 
State University Dairy Teaching and Research Center were used in a randomized 
complete block design to determine the relative bioavailability of 2 rumen-protected 
carnitine products compared to crystalline (raw) carnitine. Cows were blocked by par-
ity and level of milk production and then randomly assigned to 1 of 7 treatments within 
the block (8 cows per treatment). Cows were housed in a tie-stall facility and adapted 
for 4 days prior to 2 days of sample collection for baseline values. Following the 6-day 
baseline period, treatments were applied for a total of 8 days, with the final 2 days used 
for data and sample collection. The study was performed in 2 cohorts of cows. 
Cows were milked 3 times daily at 0400, 1000, and 1800 h. The basal diet met esti-
mated requirements for all nutrients and was fed as a total mixed ration twice daily 
(0600 and 1800 h). Animals had ad libitum access to feed in individual mangers and 
feed offered was adjusted daily to achieve 12-20% refusals. During the treatment period, 
the basal diet was top-dressed twice daily with the following treatments: a) control (no 
supplement); b) 3 grams raw carnitine; c) 6 grams raw carnitine; d) 5 grams carnitine 
with protection 1 (40% coating, 60% L-carnitine content); e) 10 grams carnitine with 
protection 1 (40% coating); f) 7.5 grams carnitine with protection 2 (60% coating, 
40% L-carnitine coating); and g) 15 grams carnitine with protection 2 (60% coating). 
Supplementation rates were designed to provide 3 or 5 grams/day carnitine, regardless 
of the protection method.
During the 2-day collection periods, feed and water intake as well as milk yield were 
recorded. Ration samples were collected on each day of both baseline and treatment 
collection periods and composited for nutrient analysis by Dairy One Forage Labora-
tory (Ithaca, NY; Table 1). Health was monitored daily and one cow (7.5 grams of 60% 
coating) was removed from the study due to illness detected by a rapid decline in dry 
matter intake (DMI). 
Over the course of the 48-hour collection period, urine and blood samples (coccygeal 
vein) were collected immediately prior to the initial feeding (2000 h), and 6, 12, and 
18 hours after feeding. Blood samples were collected into K3EDTA tubes and immedi-
ately placed on ice. Plasma was separated by centrifugation (1,500 × g for 15 minutes) 
and stored in microcentrifuge tubes at -20°C. Throughout the collection period, urine 
samples were composited by equal volumes into microcentrifuge tubes and frozen at 
-20°C until analysis of total carnitine and creatinine. Urine creatinine concentration 
and expected creatinine excretion of 29 mg/kg of BW daily was used to estimate daily 
urine volume. Two milk samples were collected at all 6 milkings during the 2-day col-
lection periods, one used for milk component analysis by Heart of America Dairy Herd 
Improvement Association (Manhattan, KS) and the other frozen until carnitine analy-
sis. Prior to analyses, the milk samples were composited in equal volumes by collection 
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period. Concentrations of total carnitine in plasma, milk, and urine were determined by 
an enzymatic radioisotope method. 
Statistical analysis was performed using SAS (version 9.3, SAS Inst., Cary, NC). The 
mixed procedure was used to model treatment response variables using the covariate for 
the same variable from the basal period, the fixed effects of treatment and parity, and 
the random effect of block. Responses were assessed with 7 contrasts that assessed the 
linear and quadratic responses to raw, 40% coating, and 60% coating carnitine treat-
ments as well as overall contrasts between raw and 40% coating, raw and 60% coating, 
and 40% vs. 60% coating treatments. Significance was declared at P < 0.05 and tenden-
cies were declared at 0.05 ≤ P ≤ 0.10.
Results and Discussion 
Production responses are summarized in Table 2. The 60% coating product linearly de-
creased DMI (P = 0.02) and raw carnitine tended to linearly decrease DMI (P = 0.07). 
The 60% coating product had a quadratic effect on milk fat percent (P = 0.04) and a 
tendency for a quadratic effect on milk yield (P = 0.07). Supplementation of raw carni-
tine had a quadratic effect on milk protein percent (P = 0.04). The 60% coating product 
tended to decrease milk protein percent (P = 0.10) and increase milk lactose percent (P 
= 0.08) compared to the 40% coating product. There were no treatment effects on milk 
yield, milk urea nitrogen, or yields of milk fat, protein, and lactose. This lack of response 
on milk yield and composition is consistent with the 6 g/day of abomasally infused raw 
carnitine found in a previous study.
Overall, there were no parity effects on plasma, milk, and urine carnitine concentra-
tions, and only a tendency for a parity effect on total daily carnitine excretion (P = 
0.10). Plasma samples were collected at 0, 6, 12, and 18 hours after feeding to assess di-
urnal variation; however, there was no effect of time on plasma carnitine concentrations 
(P = 0.23). Supplementation with raw carnitine or the 40% coating product increased 
plasma carnitine concentrations linearly (P < 0.001 and P = 0.01, respectively) whereas 
supplementation with the 60% coating product tended to linearly increase plasma car-
nitine (P = 0.08). Raw carnitine increased plasma carnitine compared to both the 40% 
coating product (P = 0.03) and the 60% coating product (P < 0.001). Urine carnitine 
concentrations also increased linearly with the raw (P = 0.03) and 40% coating prod-
ucts (P = 0.02). Effects on milk carnitine concentrations were more numerous, with 
linear effects across all sources, a quadratic tendency for the 40% coating product (P 
= 0.08). Raw carnitine increased milk carnitine concentration compared to the 60% 
coating product (P < 0.01) and tended to increased milk carnitine compared to the 
40% coating product (P = 0.08). These effects were mirrored in daily milk carnitine 
output, with linear effects seen for all forms of supplementation, a significant difference 
between the 60% coating product and raw carnitine (P < 0.01), and a tendency for a 
difference between the 40% coating product and the raw carnitine (P = 0.08). 
Conclusion
Carnitine supplementation in the forms of raw carnitine and the 40% coating product 
were effective in linearly increasing carnitine concentrations. The subtle responses seen 
for the 60% coating product, which were significantly lower than that for raw carnitine 
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in several metrics, may have been due to over-encapsulation that hindered liberation of 
the carnitine and its absorption in the small intestine. Effective ruminal protection of 
L-carnitine while maintaining intestinal availability needs further investigation.
Table 1. Ingredient and nutritional composition of the basal diet 
Item Value
Ingredient, % of dry matter 
  Corn silage 35.0
  Alfalfa hay 14.2
  Wet corn gluten feed1 27.3
  Cotton seed 2.7
  Fine-rolled corn 13.7
  Micronutrient premix2 7.0
Nutrient, % of dry matter (unless otherwise specified) 
  Dry matter, % as-fed 49.9
  Crude protein 17.5
  Acid detergent fiber 23.3
  Neutral detergent fiber 36.3
  Lignin 4.1
  Non-fiber carbohydrate 33.0
  Starch 16.2
  Crude fat 4.9
  Net energy for lactation, Mcal/lb 0.75
1Sweet Bran (Cargill Inc., Blair, NE). 
2Premix consisted of 54.6% expeller soybean meal (SoyBest, Grain States Soya, West Point, NE), 14.8% limestone, 
2.34% stock salt, 1.56 trace mineral salt, 0.16% potassium chloride, 10.9% sodium bicarbonate, 2.49% magnesium 
oxide, 0.24% 4-Plex (Zinpro Corp., Eden Prairie, MN), 0.12% Zinpro 100 (Zinpro Corp.), 0.26% selenium pre-
mix (0.06%), 0.16% vitamin A premix (30 kIU/g), 0.05% vitamin D premix (30 kIU/g), 1.56% vitamin E premix 
(48 kIU/g), 0.01% ethylenediamine dihydriodide premix, 0.07% Rumensin 90 (Elanco Animal Health, Green-
field, IN), 1.95% XP Yeast (Diamond V, Cedar Rapids, IA), 0.97% Biotin 100 (ADM Alliance Nutrition, Quincy, 
IL), and 7.8% Ca salts of long-chain fatty acids (Megalac R, Arm & Hammer Animal Nutrition, Princeton, NJ). 
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Table 2. Effect of carnitine supplementation on performance and milk production parameters 
Raw 40 coat 60 coat
Item Control 3g 6g 5g 10g 7.5g 15g SEM1
DMI,2 lb/day 60.0 59.4 57.7 59.2 58.1 57.9 56.8 2.0
Water intake,3 liters/day 128.2 131.4 128.4 136.8 120.6 125.8 125.9 5.6
Milk, lb/day 98.8 99.2 98.6 98.6 99.4 94.8 97.5 2.4
Milk fat,4 % 3.66 3.53 3.47 3.50 3.47 3.31 3.48 0.11
Milk protein,5 % 2.86 2.91 2.84 2.90 2.88 2.86 2.85 0.04
Milk lactose, % 4.92 4.94 4.92 4.92 4.89 4.95 4.95 0.03
Milk somatic cell linear score 1.61 1.46 1.96 1.22 1.53 2.01 1.21 0.48
Milk urea nitrogen, mg/dL 13.34 13.41 13.33 13.04 13.10 13.10 13.35 0.30
Milk fat, lb/day 3.62 3.42 3.44 3.51 3.35 3.15 3.42 0.15
Milk protein, lb/day 2.82 2.89 2.78 2.87 2.87 2.71 2.78 0.09
Milk lactose, lb/day 4.85 4.90 4.85 4.85 4.85 4.67 4.83 0.13
1Reported SEM is pooled across treatment groups.
2Linear effect of 60% coating product (P < 0.05).
3Quadratic effect of 40% coating product (P < 0.05).
4Quadratic effect of 60% coating product (P < 0.05).
5Quadratic effect of raw carnitine (P < 0.05).
Table 3. Least squares means for concentrations of L-carnitine in plasma, milk, and urine from mid-lactation 
Holstein cows fed different amounts and sources of L-carnitine
Raw 40 coat 60 coat
Item Control 3g 6g 5g 10g 7.5g 15g SEM1
Plasma, µM2,3,6,7 8.59 9.80 12.17 9.36 10.46 8.62 9.77 0.47
Milk
µM2,3,4,7 137.5 166.4 174.3 145.6 176.1 143.2 161.8 5.31
g/day2,3,4,7 0.97 1.17 1.22 1.05 1.22 0.99 1.15 0.03
Urine
µM2,3 9.63 10.37 11.47 10.02 11.63 9.93 10.74 0.62
g/day2,3,4,7 0.557 0.617 0.701 0.587 0.644 0.557 0.629 0.03
Total excreted carnitine,8 g/day2-7 1.52 1.78 1.92 1.62 1.87 1.54 1.79 0.04
1 Reported SEM is pooled across treatment groups.
2Linear effect of raw carnitine (P < 0.05).
3Linear effect of 40% coating product (P < 0.05).
4Linear effect of 60% coating product (P < 0.05).
5Quadratic effect of 60% coating product (P < 0.05).
640% coating product vs. raw carnitine (P < 0.05). 
760% coating product vs. raw carnitine (P < 0.05). 
8Milk plus urine carnitine. 
